🌟 Exciting News. EpiDisease SL is thrilled to announce our collaboration with CSIC, Universidad Autónoma de Madrid, NUTRINSECT, Centre of Marine Sciences (CCMAR), and IMDEA Alimentación Food as part of the DiBaN consortium funded with an @European Innovation Council Pathfinder grant! 🌟 By joining this esteemed group, we will leverage our expertise in epigenetics and biomarkers to enhance the consortium's mission of tackling metabolic diseases and intestinal dysbiosis through innovative nutritional solutions. Together, we are committed to advancing research and developing effective interventions that will significantly improve public health. Stay tuned for updates on our journey! #EpiDisease #DiBaNConsortium #PublicHealth #T2D #MetabolicDiseases #Innovation www.epidisease.com https://lnkd.in/emDQwgS5
EpiDisease SL’s Post
More Relevant Posts
-
🚨 New research sheds light on the gut-brain connection in Parkinson’s treatment! A study led by Dr. Fatima Pereira and a team of international researchers from the University of Southampton, Vienna, Boston, and Aalborg has uncovered how the commonly prescribed Parkinson’s drug entacapone disrupts the gut microbiome. The research, published in Nature Microbiology, reveals that entacapone starves beneficial gut microbes of iron, potentially leading to health complications. 👉 Read the full article and discover how this research could inform better therapies for the millions living with Parkinson’s disease: https://lnkd.in/eUtKP_fG #ParkinsonsDisease #GutMicrobiome #MedicalResearch #Innovation
To view or add a comment, sign in
-
🔬 You didn't join us at our last conference, but you have an interest in microbiomes? Don't worry, we've got you covered! 📽️ Dive into the fascinating talks from #HumanMicrobiomeAction experts as they explore the field of microbiome research and how important it is to treating chronic illnesses. Explore fascinating insights on the latest breakthroughs, innovative therapies, and potential game-changers in healthcare.⚕️ From exploring the gut-brain axis to discussing personalized medicine approaches, this recording offers a glimpse into the forefront of scientific discovery. Don't miss your chance to catch up on the latest advancements - watch now! 👇 Microbiology Society Pharmabiotic Research Institute (PRI) Céline Druart MetaGenoPolis The Gut Health Doctor Joel DORE The Microbiome Times APC Microbiome Ireland, SFI Research Centre Novo Nordisk Foundation Center for Basic Metabolic Research INRAE Transfert SAS INRAE KPL Paris Technical University of Munich European Foundation for the Study of Chronic Liver Failure (EF CLIF)
To view or add a comment, sign in
-
Tezted presents: Recent high-quality scientific studies. This week's paper is Field-Cortazares et al 2025 https://lnkd.in/dWxs5Scw. 🔬 Exciting Research Alert! 🔬 Did you know about the potential threat of rickettsiosis in Mexico? 🦠Rickettsiosis, caused by the obligate intracellular bacterium R. rickettsii, is transmitted by ticks and can infect various vertebrates, including humans. Symptoms range from high fever and headache to abdominal pain and cough, with untreated cases having mortality rates as high as 30%. In a groundbreaking study conducted in Ensenada, Baja California, researchers aimed to shed light on the presence of rickettsiosis in the region, where no human cases had been reported before. Between October 2009 and August 2011, 384 patient samples were analyzed. Using advanced techniques, including ELISA and immunofluorescence assays, the team found a seroprevalence of 3.9% for R. rickettsii in humans. Interestingly, this prevalence wasn't associated with demographic factors or the movement of dogs between home and street, suggesting a complex transmission pattern. The study's findings, demonstrating substantial agreement between different diagnostic methods, provide crucial insights into the prevalence and potential risks of rickettsiosis in the region. This research highlights the importance of ongoing surveillance and awareness efforts to combat emerging infectious diseases. Stay informed, stay safe! 🌐💉 #RickettsiosisResearch #PublicHealth #EnsenadaScience #TickBorneDisease #TICKPLEX www.labomedishi.com.mx www.tezted.com
To view or add a comment, sign in
-
Tezted presents: Recent high-quality scientific studies. This week's paper is Field-Cortazares et al 2025 https://lnkd.in/g6URekW3. 🔬 Exciting Research Alert! 🔬 Did you know about the potential threat of rickettsiosis in Mexico? 🦠Rickettsiosis, caused by the obligate intracellular bacterium R. rickettsii, is transmitted by ticks and can infect various vertebrates, including humans. Symptoms range from high fever and headache to abdominal pain and cough, with untreated cases having mortality rates as high as 30%. In a groundbreaking study conducted in Ensenada, Baja California, researchers aimed to shed light on the presence of rickettsiosis in the region, where no human cases had been reported before. Between October 2009 and August 2011, 384 patient samples were analyzed. Using advanced techniques, including ELISA and immunofluorescence assays, the team found a seroprevalence of 3.9% for R. rickettsii in humans. Interestingly, this prevalence wasn't associated with demographic factors or the movement of dogs between home and street, suggesting a complex transmission pattern. The study's findings, demonstrating substantial agreement between different diagnostic methods, provide crucial insights into the prevalence and potential risks of rickettsiosis in the region. This research highlights the importance of ongoing surveillance and awareness efforts to combat emerging infectious diseases. Stay informed, stay safe! 🌐💉 #RickettsiosisResearch #PublicHealth #EnsenadaScience #TickBorneDisease #TICKPLEX www.labomedishi.com.mx www.tezted.com
To view or add a comment, sign in
-
From faecal transplants to microbial medicines, our “Babbage” podcast explores the microbiome treatments that could change medicine. Listen now
How to fix a faulty microbiome
economist.com
To view or add a comment, sign in
-
FREE WEBINAR Host-Microbiota Interactions: A Personalized Point of View Date: April 18 Time: 9 am - 10 am CT Join IAFNS as we hear from Dr. Benoit Chassaing, Team Leader at INSERM located at Institut Pasteur in Paris, where his laboratory focuses on mucosal microbiota in chronic inflammatory diseases. The central objective of his research team is to study the composition and function of the microbiota at the mucosal surface, in both health and disease states, using both pre-clinical models and clinical approaches. In this presentation, Dr. Chassaing will cover recent advances made toward a better understanding of the central role played by mucus-associated bacteria in chronic inflammatory diseases, as well as the extent to which microbiota assessment will enable, in the coming years, precision nutrition and medicine. Register here: https://lnkd.in/gAxiaTq7
register.gotowebinar.com
To view or add a comment, sign in
-
🔬 Exploring New Horizons in Myeloproliferative Neoplasms (MPN) 🧬 Professor Rao Tata Negeswara invites us to delve into the world of MPN, highlighting the importance of ongoing research and diet in managing these diseases. From genetic mutations to the impact of proper nutrition, every detail matters in improving the quality of life for patients. 🚀 Negeswara emphasizes the power of predictive models and targeted therapies, opening doors to personalized treatments that can change the landscape of MPN. Additionally, he reveals promising findings from his laboratory, including biomarkers that predict disease progression. 📚 Would you like to learn more about how science and nutrition can transform the lives of those facing MPN? Discover all the details in our new blog article. https://lnkd.in/dAkA5Zxy
To view or add a comment, sign in
-
𝗖𝗮𝗻 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝗴𝘂𝘁 𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝘁𝗮 𝗱𝗿𝗶𝘃𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗶𝗻 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝘀𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀? Today's article explores how the composition of gut microbiota influences the progression of Multiple Sclerosis (MS) over time, focusing on microbial markers and metabolic pathways associated with disease severity and clinical outcomes. Key findings: • Longitudinal study of MS patients reveals microbial differences between progressors and non-progressors. • Specific bacterial species, including Akkermansia and Prevotella-9, are associated with disease worsening. • Metagenomic analysis suggests shifts towards oxidative stress-inducing pathways and reduced SCFA metabolism in progressors, making them potential therapeutic avenues. • Gut microbiota composition shows potential as a predictive biomarker for MS progression. Full citation: Montgomery, T.L., Wang, Q., Mirza, A. et al. Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis. Sci Rep 14, 15292 (2024). https://lnkd.in/ekaD4Yfr Freely available under a Creative Commons license: https://lnkd.in/dyuva2r8 #science #metabolism #precisionmedicine #microbiotaeducation
To view or add a comment, sign in
-
The gut microbiome plays a pivotal role in maintaining human health, influencing everything from digestion and metabolism to immune function and even mental health. An imbalance in this complex microbial ecosystem has been linked to a wide range of conditions, including inflammatory bowel disease, obesity, diabetes, and neurological disorders. As a result, understanding the gut microbiome has become crucial for advancing personalized medicine, nutrition, and therapeutic strategies. Next-Generation Sequencing (NGS) technologies, particularly 16s rRNA sequencing, have revolutionized microbiome research by enabling in-depth analysis of microbial communities with unmatched speed and precision. These NGS-based methods allow researchers to explore the diversity and function of gut microorganisms, providing insights that were previously unattainable. We are happy to announce our upcoming workshop on Metagenomics Data Analysis which will deep dive into these cutting-edge NGS techniques. By learning how to process and analyze 16s rRNA sequencing data, participants will gain the skills needed to advance research and clinical applications in this rapidly evolving field. Whether you're working in healthcare, academia, or biotechnology, mastering these techniques is essential for anyone looking to contribute to the future of microbiome science. Register here: https://lnkd.in/dtNR9ghb #Metagenomics #GutMicrobiome #Bioinformatics #HumanHealth
To view or add a comment, sign in
-
"Nutrition" can be like magic, illustrated by this paper in Ped Res showing that colostrum (nasal instillation) is a strong stimulator of neurogenic growth of nerve tissue, in a murine model. Great basic science, looking fw to see if/how this can be translated in clinical research! #UENPS https://lnkd.in/dMfRPXBH
To view or add a comment, sign in
2,180 followers